Target intelligence / Profile preview

DOCK6 antisense RNA 1 (DOCK6-AS1)

Target
DOCK6-AS1
Molecular classification
Long non-coding RNA (lncRNA), Non-coding RNA (ncRNA)
01

Overview

DOCK6 antisense RNA 1 (DOCK6-AS1, also called AC011472.4) is a long non-coding RNA gene annotated in the human genome[1][3][5]. It is located in the antisense orientation to the DOCK6 gene locus. Like other antisense lncRNAs, DOCK6-AS1 may act in the regulation of the neighboring DOCK6 gene or participate in broader regulation of gene networks, but no specific biological or pathological functions have been reported for DOCK6-AS1 itself in the scientific literature to date[1][3][5]. There are no current reports identifying DOCK6-AS1 as a protein-coding gene, therapeutic target, clinical biomarker, or gene with a known role in disease. The DOCK6 protein, in contrast, is a guanine nucleotide exchange factor involved in cytoskeletal organization[7], but there is no evidence that DOCK6-AS1 shares these properties or functions. Summary: - DOCK6-AS1 is a gene encoding a long non-coding antisense RNA relative to the DOCK6 coding gene. - It is not a receptor, enzyme, or druggable target and is not associated with any drugs, mechanisms of action, or established disease roles[1][3][5]. - Its precise function remains to be experimentally determined.

Other names
AC011472.4
02

Biological functions

Unknown (Specific molecular or cellular functions of DOCK6-AS1 have not been experimentally described. By analogy with other antisense lncRNAs, it may be involved in regulation of gene expression, including the DOCK6 locus.)
03

Disease associations

Unknown (No direct disease associations have been established for DOCK6-AS1, and no studies indicate direct involvement in major disease categories as of the current literature.)

Beyond the preview

Go deeper on DOCK6 antisense RNA 1 (DOCK6-AS1).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on DOCK6 antisense RNA 1 (DOCK6-AS1).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call